Novel Drug Delivery System Market
Growing prevalence of chronic diseases, drug innovation, and the rising biologics market is also contributing to the growth of novel drug delivery systems market
Growing prevalence of chronic diseases, drug innovation, and the rising biologics market is also contributing to the growth of novel drug delivery systems market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REPORT DESCRIPTION<br />
<strong>Novel</strong> <strong>Drug</strong> <strong>Delivery</strong> <strong>System</strong> <strong>Market</strong> : Taxonomy<br />
Growing prevalence of chronic diseases, drug innovation, and the rising biologics<br />
market is also contributing to the growth of novel drug delivery systems market.<br />
According to data published by Fraser Institute Canada in July 2016, around 22%<br />
of overall sales of pharmaceutical firms in 2013 and expected to reach 32% by 2023<br />
globally. The global spending on biologics has increased by 7% as compared to<br />
previous year.<br />
Effectiveness of novel drug delivery system in cancer therapy is also a major factor<br />
propelling the novel drug delivery systems market growth. For instance, according<br />
to the data published by International Journal of Pharma Sciences and Research<br />
(IJPSR), around 9 million deaths occurred due to cancer in 2015 and estimations<br />
reveal that around 11.4 million people are expected to die due to cancer by 2030.<br />
Request Report Sample @<br />
https://www.coherentmarketinsights.com/insight/request-sample/801<br />
© Coherent market Insights. All Rights Reserved
Change language